Literature DB >> 19152244

E-Cadherin truncation and sialyl Lewis-X overexpression in oral squamous cell carcinoma and oral precancerous conditions.

M H Shah1, R N Sainger, S D Telang, G H Pancholi, S N Shukla, P S Patel.   

Abstract

The present study aimed to determine significance of E-cadherin, a cell adhesion molecule, and sialyl Lewis-X (sLeX), a cell surface antigen, in oral carcinogenesis. Expressions of E-cadherin and sLeX were detected using western blot analysis from oral malignant (n=25), and oral precancerous tissues (OPC, n=20) and their adjacent normal tissues. An altered expression of E-cadherin (E-cad) and sLeX was observed in malignant and precancerous tissues. E-cad western blot revealed presence of two bands, a 120 kDa (native, E-cad120) and a 97 kDa (known as truncated E-cad97). The accumulation of truncated E-cad97 and sLeX in malignant and OPC tissues compared to their adjacent normal tissues was observed. Receiver's Operating Characteristics (ROC) curve analysis showed good discriminatory efficacy of E-cad97, E-cad97:120 ratio and sLeX between the malignant and adjacent. normal tissues. Further, a positive correlation of E-cad97 and sLeX overexpression with advanced stage of the disease and lymphnode metastasis was observed. The data suggest that E-cadherin truncation and sLeX overexpression are early events which may facilitate the tumor cells to metastasize. Also, overexpression E-cad97 and sLeX in OPC tissues may be useful to predict metastatic potentials of tumors at an early stage of oral carcinogenesis. Key words: Oral cancer, oral precancerous conditions, E-cadherin, sialyl Lewis-X, metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19152244     DOI: 10.4149/neo_2009_01_40

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  8 in total

Review 1.  Glycosylation: a hallmark of cancer?

Authors:  Bhairavi N Vajaria; Prabhudas S Patel
Journal:  Glycoconj J       Date:  2016-12-14       Impact factor: 2.916

2.  Inhibition of adhesion and metastasis of HepG2 hepatocellular carcinoma cells in vitro by DNA aptamer against sialyl Lewis X.

Authors:  Xiao-Kang Wang; Yan Peng; Hao-Ran Tao; Fen-Fang Zhou; Chi Zhang; Fei Su; Shi-Pei Wang; Qing Liu; Li-Hua Xu; Xue-Kai Pan; Wei Xie; Mao-Hui Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

3.  Lewis x Antigen is Associated to Head and Neck Squamous Cell Carcinoma Survival.

Authors:  Martín E Rabassa; Adrian Pereyra; Liliana Pereyra; Amada Segal-Eiras; Martín C Abba; Maria V Croce
Journal:  Pathol Oncol Res       Date:  2017-07-05       Impact factor: 3.201

4.  Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.

Authors:  Thomas Kolben; Lena Müller; Sarah Meister; Lucia Keilmann; Christina Buschmann; Fabian Trillsch; Alexander Burges; Bastian Czogalla; Sophie Mitter; Elisa Schmoeckel; Stefanie Corradini; Sven Mahner; Udo Jeschke; Mirjana Kessler; Susanne Beyer
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-21       Impact factor: 4.322

5.  In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells.

Authors:  Michael J Czerwinski; Vincenzo Desiderio; Omar Shkeir; Petros Papagerakis; Martian C Lapadatescu; John H Owen; Maria Athanassiou-Papaefthymiou; Li Zheng; Gianpaolo Papaccio; Mark E Prince; Silvana Papagerakis
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04-04       Impact factor: 3.497

6.  E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.

Authors:  Sandra Ventorin von Zeidler; Talitha de Souza Botelho; Elismauro Francisco Mendonça; Aline Carvalho Batista
Journal:  BMC Cancer       Date:  2014-12-17       Impact factor: 4.430

7.  Expression of E- Cadherin and Levels of Dysplasia in Oral Leukoplakia - A Prospective Cohort Study.

Authors:  I Ilangani Sathish; Kannan Asokan; Krithika C L; Arvind Ramanathan
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

8.  Exploring the classification of cancer cell lines from multiple omic views.

Authors:  Xiaoxi Yang; Yuqi Wen; Xinyu Song; Song He; Xiaochen Bo
Journal:  PeerJ       Date:  2020-08-18       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.